pruritus

Doxepin Therapeutic Cheat Sheet
Doxepin
by Michael J. Visconti, DO on
As dermatologists, pruritus (or itch) is one of the most frequent symptoms that we encounter. The broad spectrum of itch severity in patients with various dermatologic conditions suggests a need for a host of “tools” or medications that dermatologists should have in their toolbox. In this publication, we continue our Therapeutic Cheat Sheet series by highlighting the uses of Doxepin in dermato …

Continue reading "Doxepin Therapeutic Cheat Sheet"

Atopic Dermatitis (AD) Treatment Initiation and Monitoring
atopic dermatitis (AD)
by Mojgan Hosseinipour, DO, FAAD on
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.  CASE 1 51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA …

Continue reading "Atopic Dermatitis (AD) Treatment Initiation and Monitoring"

Skincare Mondays | Colloidal Oatmeal: Composition, Benefits & Mechanism of Action
Colloidal Oatmeal
by Johnson & Johnson Consumer Health on
Colloidal oatmeal has a long history of use in the treatment of dermatologic disease. Oat is composed of various phytochemicals which contribute to its wide-ranging function and clinical use in atopic dermatitis and other skin conditions resulting from an impaired skin barrier and inflammation. OAT COMPOSITION & BENEFITS The main components of colloidal oatmeal are polysaccharides (including …

Continue reading "Skincare Mondays | Colloidal Oatmeal: Composition, Benefits & Mechanism of Action"

Tralokinumab-ldrm Therapeutic Cheat Sheet
tralokinumab
by Emily Murphy, MD on
Atopic dermatitis is a common, chronic, life-altering disease. With its visibility and debilitating pruritus, atopic dermatitis significantly impacts our patients’ quality of life. For those with resistant and extensive disease, we are happy to have numerous new systemic agents at our disposal, one being tralokinumab, an IL-13 antagonist. We continue our series, Therapeutic Cheat Sheet, with a c …

Continue reading "Tralokinumab-ldrm Therapeutic Cheat Sheet"

Skincare Mondays | Data-Driven Dermatology Improves Patient Outcomes
data driven dermatology
by AveenoMD on
Data-Driven Dermatology Improves Patient Outcomes The use of real-world data and real-world evidence to inform health care decisions is increasing. While randomized controlled trials (RCTs) are still the gold standard for evidence-based medicine, the strict inclusion/exclusion criteria and tightly controlled conditions limit their generalizability to real-world clinical practice.  Real worl …

Continue reading "Skincare Mondays | Data-Driven Dermatology Improves Patient Outcomes"